A study recently published in Translational Psychiatry, a Nature journal, has shown how using cultured cells from patients with psychotic disorders, such as schizophrenia, to investigate abnormalities in nerve connections in the brain could lead to new treatments. Strong correlations were observed between the findings in the cells in culture—grown outside the body in a controlled environment—and findings from brain imaging performed on the same human participants.
“The findings are important, because if the health of cells in culture reflects the health of the same cells in a human brain, we may be able to create a better model for studying psychotic disorders,” said the study’s senior author, Bruce M. Cohen, MD, PhD, director of McLean Hospital’s Program for Neuropsychiatric Research (PNPR). Cohen said such a model could give researchers a greater capacity to find genetic and biochemical targets in the brain. Using these targets, he said, “could enable us to develop novel and more effective interventions for psychotic disorders.”
For their work, Cohen and his colleagues, including first author Donna L. McPhie, PhD, director of the Cellular Neuropsychiatry Laboratory in the PNPR, drew on studies showing that altered pathways of brain development can be found across most cases of schizophrenia and that inaccurate connections and “leaks” in signaling between nerve cells are a feature of many psychotic disorders. A substance called myelin, produced by cells called oligodendrocytes, serves as a kind of insulation to prevent these leaks. In studies at McLean Hospital by co-author Dost Öngür, MD, PhD, chief of the Psychotic Disorders Division at McLean, and his colleagues, myelin was measured and found to be reduced in the brain in patients with schizophrenias.
Based on this prior research, Cohen and his colleagues drew on a repository of cell lines they had obtained from patients with psychiatric disorders. These samples were reprogrammed from skin cells into brain-like cells in the laboratory. The reprogrammed cell lines, taken from both ill and healthy patients, produced nerve cells and support cells called glia, including oligodendrocytes, in laboratory cultures. Investigations into these cells revealed significant abnormalities in the development of oligodendrocytes grown from subjects with psychotic disorders.
The research also revealed a strong correlation between the number of oligodendrocytes in culture and the amount of myelin made by these cells in the brains of the same subjects who provided the cells. This finding, Cohen explained, “means that we can now study the causes of the abnormality of myelin that we have observed in living brain tissue in a laboratory setting.”
For Cohen and his colleagues, the prospect of using lab cultures to examine differences in the brains of individuals with psychotic illnesses is “an exciting development.” For example, Cohen said, researchers have observed that not all genes and proteins necessary to make oligodendrocytes are affected in these cells, and they can now begin to identify exactly what genes and proteins are different in these cells. It would be impossible, he said, to do these detailed studies in living brain tissue.
Such studies, the researchers believe, could lead to better treatment approaches for individuals with psychotic conditions. “Using in vitro cell cultures to study these abnormalities could help us identify specific genetic and biochemical targets that might be addressed by novel drug treatments, cell transplantation, or other interventions,” Cohen said.
The Latest on: Schizophrenia
via Google News
The Latest on: Schizophrenia
- MD Magazine® Launches Schizophrenia Treatment Approaches and Relapse Prevention Video Series on April 17, 2019 at 10:43 am
CRANBURY, N.J.--(BUSINESS WIRE)--MD Magazine®, a digital portal focused on providing physicians with the most valuable and up-to-date specialty- and disease-specific resources to help them provide the ... […]
- Marijuana For Treating Schizophrenia And Tourette Syndrome on April 17, 2019 at 10:14 am
Regardless of the history of marijuana in folk pharmacopoeias, its clinical studies on medicinal effects are still limited in most areas. However, there are preliminary results of research on this ... […]
- Political Schizophrenia on April 17, 2019 at 3:35 am
In the 1950s, my father was a young boy growing up in rural Tennessee near Memphis. He picked cotton and strawberries, slaughtered hogs, hunted rabbit, and swam in the mud creeks filled with water ... […]
- Benny and Joon and a Good Look at Schizophrenia on April 16, 2019 at 1:40 pm
Bruce Chadwick lectures on history and film at Rutgers University in New Jersey. He also teaches writing at New Jersey City University. He holds his PhD from Rutgers and was a former editor for ... […]
- Early Stresses Contribute to Schizophrenia on April 16, 2019 at 5:20 am
Patients with schizophrenia were found to be vulnerable to environmental factors that are expressed as schizophrenia, including environmental stress in utero, possibly due to inadequate stress ... […]
- ALKS 3831 mitigates weight gain in phase 3 schizophrenia study on April 16, 2019 at 4:13 am
Patients with schizophrenia treated with ALKS 3831, a combination of olanzapine and samidorphan, had less weight gain than those treated with olanzapine alone, according to a presentation from the ... […]
- How to Treat Schizophrenia, According to a Psychiatrist on April 15, 2019 at 9:25 am
Schizophrenia is a complex, lifelong disorder that needs specialized, long-term treatment—and it’s a disorder that tends to be even harder to treat than other mental illnesses. “We aren’t sure why, ... […]
- More Evidence Schizophrenia Combo Therapy Blunts Weight Gain on April 15, 2019 at 8:50 am
"Olanzapine is one of the most effective antipsychotics that we have, but its use has been limited by the weight gain and waist circumference increases that are associated with it. This new ... […]
- Gluten-Free Diet May Ease Schizophrenia Symptoms on April 15, 2019 at 7:18 am
ORLANDO, Florida — A gluten-free diet may reduce symptoms in a particular subset of patients with schizophrenia, early research suggests. In a small pilot study, investigators found individuals with ... […]
via Bing News